Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

Vangent forges alliance with MSM in Atlanta to provide job opportunities for MPH degree students

Vangent, Inc., a leading global provider of information management and strategic business process outsourcing solutions, announced it has partnered with the Morehouse School of Medicine (MSM) in Atlanta, GA to provide job opportunities for some of Morehouse's second year graduate students pursuing a Master of Public Health (MPH) degree.

9 Sep 2009

Cardiac Network increases the number of sites for its research study

Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it has expanded the number of sites included in its research study support with Southern California Permanente Medical Group.

9 Sep 2009

New findings may help identify treatments for diabetes and hyperinsulinemia

By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion. The mechanism involves a protein called ankyrin, which UI researchers previously linked to potentially fatal human heart arrhythmias.

9 Sep 2009

Regular usage of CGM devices help manage diabetes

The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.

9 Sep 2009

FDA approves the distribution of IMRISNV and IMRIScardio systems

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States.

9 Sep 2009

Wellmont partners with HealthSouth to open a new inpatient rehabilitation hospital in Bristol

Wellmont Health System and HealthSouth Corporation (NYSE: HLS) today announced that a joint venture entity formed by the two parties has been awarded a certificate of public need (COPN) to open a new inpatient rehabilitation hospital in Bristol, Va. The 25-bed hospital will enable more patients in Bristol and throughout Southwest Virginia to have access to comprehensive, high-quality rehabilitative services.

9 Sep 2009

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.

8 Sep 2009

Exposure to air pollution can cause heart attack

It's well known that measures such as exercise, a healthy diet and not smoking can help reduce high blood pressure, but researchers at the University of Michigan Health System have determined the very air we breathe can be an invisible catalyst to heart disease.

8 Sep 2009

Stemedica files patent application for diabetic retinopathy treatment

Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, has filed a patent application with the United States Patent and Trademark Office ("USPTO") for a proprietary methodology in the treatment for Diabetic Retinopathy.

8 Sep 2009

Prevalence of cortical gray matter atrophy may be overestimated in healthy aging brain

The belief that healthy older brains are substantially smaller than younger brains may stem from studies that did not screen out people whose undetected, slowly developing brain disease was killing off cells in key areas, according to new research. As a result, previous findings may have overestimated atrophy and underestimated normal size for the older brain.

8 Sep 2009

The Jordanian Stem Cell Company signs purchase agreement with Stemedica International

Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.

7 Sep 2009

Harmless shard from childhood virus shell may halt biological process

A harmless shard from the shell of a common childhood virus may halt a biological process that kills a significant percentage of battlefield casualties, heart attack victims and oxygen-deprived newborns, according to research presented Sunday, September 6, 2009, at the 12th European meeting on complement in human disease in Budapest, Hungary.

7 Sep 2009

CIHR funds for Alzheimer's and stroke research

The Canadian Institutes of Health Research (CIHR) has announced a grant totaling more than a million dollars for John F. MacDonald's research on Alzheimer's disease.

7 Sep 2009

Proposed Medicare cuts worry seniors and nursing homes

As Congress prepares to reconvene next week following an August recess replete with wide-ranging local discussion of how to fund health care reform, new polling finds both seniors and the public at large are strongly opposed to slashing Medicare-funded nursing home care to pay for the plan. Meanwhile, at events in Florida and Pennsylvania - states with large concentrations of Medicare beneficiaries - seniors and caregivers are urging their respective state congressional delegations to help preserve, protect and defend quality nursing home care as the legislative debate resumes Tuesday on Capitol Hill.

5 Sep 2009

Insomnia increases blood pressure

Can't sleep at night? A new study published in the journal Sleep has found that people who suffer from insomnia have heightened nighttime blood pressure, which can lead to cardiac problems. The investigation, which measured the 24-hour blood pressure of insomniacs compared to sound sleepers, was conducted by researchers from the Universit- de Montr-al, its affiliated H-pital du Sacr--C-ur de Montr-al Sleep Disorders Centre and the Universit- Laval.

5 Sep 2009

The 2009 Heart and Stroke Foundation Report on health of Ontario's kids

In 1998, the Heart and Stroke Foundation's Report Card on Canada's Kids took a hard look at the heart health of Canadian children aged 6-12. More than 10 years later, the Foundation shines the spotlight on Ontario's kids - and will be issuing its own Report Card on the heart health of this young cohort.

4 Sep 2009

Covidien's Sleep Diagnostic business acquired by Embla

Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien's Sleep Diagnostic business. This includes the sleep diagnostic products sold under the Sandman(TM) brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.

4 Sep 2009

Brain screening tests may do more harm than good

Researchers warn that paid-for brain scans - increasingly popular with healthy people who want to allay fears about undiagnosed brain cancer and stroke - may do more harm than good.

4 Sep 2009

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

For economists and policy-makers to understand the true value of the costs and savings of preventive health programs for chronic disease, the Congressional Budget Office (CBO) should incorporate long-term clinical outcomes data and look beyond the 10-year window when making cost estimates, says a team of University of Chicago researchers in today's issue of Health Affairs.

3 Sep 2009